newsfilter
← Latest News
GlobeNewswire·

LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation

Exemption from the $5.1 million repayment obligation strengthens LAVA's balance sheet Underscores focus on cost curtailment and strategic option evaluation UTRECHT, The Netherlands and PHILADELPHIA, April 16, 2025